Cellular cholesterol efflux to serum is impaired in diabetic nephropathy

Diabetes/Metabolism Research and Reviews

Volumn 24, Issue 8, 2008, Pages 617-623

  Zhou, Huali ^a   Tan, Kathryn C B ^a   Shiu, Sammy W M ^a   Wong, Ying ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

ATP binding cassette transporter A1; Cholesterol efflux; Diabetic nephropathy; Scavenger receptor class B type I

Indexed keywords

ABC TRANSPORTER A1; ADVANCED GLYCATION END PRODUCT; APOLIPOPROTEIN A1; CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ORAL ANTIDIABETIC AGENT; PRE BETA HIGH DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR BI; ABC TRANSPORTER; CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN; LIPID; MESSENGER RNA; SCARB1 PROTEIN, HUMAN; SCAVENGER RECEPTOR B; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DYSLIPIDEMIA; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN TREATMENT; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEINURIA; RAT; SERUM; ALBUMINURIA; ANALYSIS OF VARIANCE; BLOOD; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; TRANSPORT AT THE CELLULAR LEVEL;

ALBUMINURIA; ANALYSIS OF VARIANCE; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; MALE; MIDDLE AGED; PROTEINURIA; RNA, MESSENGER; SCAVENGER RECEPTORS, CLASS B;

EID: 60849115896     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.895     Document Type: Article

References (20)

1. von Eckardstein A, Nofer JR, Assmann G. High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 2001; 21: 13-27.
2. Lewis GF. Determinants of plasma HDL concentrations and reverse cholesterol transport. Curr Opin Cardiol 2006; 21: 345-352.
3. Jessup W, Gelissen IC, Gaus K, Kritharides L. Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages. Curr Opin Lipidol 2006; 17: 247-257.
4. Lewis GF, Rader DJ. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 2005; 96: 1221-1232.
5. Pajunen P, Syvänne M, Castro G, Nieminen MS, Taskinen MR. Cholesterol efflux capacity in vitro predicts the severity and extent of coronary artery disease in patients with and without type 2 diabetes. Scand Cardiovasc J 2001; 35: 96-100.
6. Mikkola TS, Anthony MS, Clarkson TB, St Clair RW. Serum cholesterol efflux potential is an independent predictor of coronary artery atherosclerosis. Atherosclerosis 2003; 170: 31-38.
7. Syvanne M, Castro G, Dengremont C, et al. Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I: A-II particles and phospholipid transfer protein. Atherosclerosis 1996; 127: 245-253.
8. Zhou HL, Tan KC, Shiu S, Wong Y. Increasedserum advanced glycation end products is associated with impairment in HDL antioxidative capacity in diabetic nephropathy. Nephrol Dial Transplant 2008; 23: 927-933.
9. de Vries R, Groen AK, Perton FG, et al. Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: Roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification. Atherosclerosis 2008; 196: 733-741.
10. Attman PO, Knight-Gibson C, Tavella M, Samuelsson O, Alaupovic P. The compositional abnormalities of lipoproteins in diabetic renal failure. Nephrol Dial Transplant 1998; 13: 2833-2841.
11. Hirano T, Sakaue T, Misaki A, et al. Very low-density lipoprotein-apoprotein CI is increased in diabetic nephropathy: comparison with apoprotein CIII. Kidney Int 2003; 63: 2171-2177.
12. Favari E, Lee M, Calabresi L, et al. Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein. J Biol Chem 2004; 279: 9930-9936.
13. Passarelli M, Tang C, McDonald TO, et al. Advanced glycation end product precursors impair ABCA1-dependent cholesterol removal from cells. Diabetes 2005; 54: 2198-2205.
14. Bortnick AE, Rothblat GH, Stoudt G, et al. The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J Biol Chem 2000; 275: 28634-28640.
15. Costet P, Luo Y, Wang N, Tall AR. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem 2000; 275: 28240-28245.
16. Tan KCB, Chow WS, Ai VHG, Metz C, Bucala R, Lam KSL. Advanced glycation end products and endothelial dysfunction in type 2 diabetes mellitus. Diabetes Care 2002; 25: 1055-1059.
17. Vogt L, Laverman GD, van Tol A, Groen AK, Navis G, Dullaart RP. Cellular cholesterol efflux to plasma from proteinuric patients is elevated and remains unaffected by antiproteinuric treatment. Nephrol Dial Transplant 2006; 21 101-106.
18. Adorni MP, Zimetti F, Billheimer JT, et al. The roles of different pathways in the release of cholesterol from macrophages. J Lipid Res 2007; 48: 2453-2462.
19. Fournier N, Francone O, Rothblat G, et al. Enhanced efflux of cholesterol from ABCA1-expressing macrophages to serum from type IV hypertriglyceridemic subjects. Atherosclerosis 2003; 171: 287-293.
20. Attia N, Ramaharo A, Paul J-L, et al. Enhanced removal of cholesterol from macrophage foam cells to serum from type IV hypertriglyceridemic subjects. Atherosclerosis 2008; 198: 49-56.